Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is associated with a high rate of thrombotic complications, which are prevented using systemic anticoagulation and surface coating technologies. Heparin and phosphorylcholin (PPC) coatings are widely used in clinical practice, but little is known about their effectiveness in VA-ECMO setting.

Objectives: To compare the effects of heparin and PPC coatings on thrombotic complications, bleeding, blood trauma, inflammation, thrombi composition, and mortality.

Methods: A retrospective multicenter clinical cohort was studied for clinical endpoints, and a prospective histologic cohort was investigated for thrombi composition. The clinical cohort included adult patients supported by VA-ECMO for cardiogenic shock, without any constitutive or acquired hemostasis disease disorder, from January 2013 to December 2020. Thrombi retrieved from circuit junctions underwent histochemical and immunochemical analysis for erythrocytes, von Willebrand factor (VWF), platelets, fibrinogen, and neutrophil extracellular traps content. The clinical cohort was compared using a propensity score overlap weighting. A P value <.05 was significant.

Results: Compared with PPC coating, heparin coating was associated with a lower incidence of thrombotic complications before and after propensity score overlap weighting (hazard ratio [HR]: 0.67; 95% CI: 0.48-0.93; P = .015), a lower decrease in hemoglobin, but a greater decrease in platelet count. In the histologic analysis, PPC coating resulted in a greater content of VWF. The other endpoints were similar among groups.

Conclusion: Compared with PPC coating, heparin coating is associated with fewer thrombotic complications during VA-ECMO support. Kinetics of platelet count and hemoglobin, thrombi contents differed according to coating types.

Trial Registration: The prospective substudy is ancillary to the WITECMO-H multicenter study registered at ClinicalTrial.gouv (NCT03070912).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtha.2025.02.020DOI Listing

Publication Analysis

Top Keywords

clinical cohort
12
surface coating
8
veno-arterial extracorporeal
8
extracorporeal membrane
8
membrane oxygenation
8
propensity score
8
thrombotic complications
8
ppc coatings
8
thrombi composition
8
clinical
6

Similar Publications

To analyze in-hospital mortality in children undergoing congenital heart interventions in the only public referral center in Amazonas, North Brazil, between 2014 and 2022. This retrospective cohort study included 1041 patients undergoing cardiac interventions for congenital heart disease, of whom 135 died during hospitalization. Records were reviewed to obtain demographic, clinical, and surgical data.

View Article and Find Full Text PDF

Importance: Behavioral variant frontotemporal dementia (bvFTD), the most common subtype of FTD, is a leading form of early-onset dementia worldwide. Accurate and timely diagnosis of bvFTD is frequently delayed due to symptoms overlapping with common psychiatric disorders, and interest has increased in identifying biomarkers that may aid in differentiating bvFTD from psychiatric disorders.

Objective: To summarize and critically review studies examining whether neurofilament light chain (NfL) in cerebrospinal fluid (CSF) or blood is a viable aid in the differential diagnosis of bvFTD vs psychiatric disorders.

View Article and Find Full Text PDF

Importance: Survivors of critical illness often have ongoing issues that affect functioning, including driving ability.

Objective: To examine whether intensive care unit (ICU) delirium is independently associated with long-term changes in driving behaviors.

Design, Setting, And Participants: This multicenter, longitudinal cohort study included 151 survivors of critical illness residing within 200 miles of Nashville, Tennessee.

View Article and Find Full Text PDF

Importance: Right anomalous aortic origin of a coronary artery (R-AAOCA) is a rare congenital condition increasingly diagnosed with the growing use of cardiac imaging. Due to dynamic compression of the anomalous vessel, invasive fractional flow reserve (FFR) during a dobutamine-atropine volume challenge (FFR-dobutamine) is considered the reference standard. A reliable alternative method is needed to reduce extensive invasive testing, but it remains uncertain whether noninvasive imaging can accurately assess the hemodynamic relevance of R-AAOCA.

View Article and Find Full Text PDF